These multilineage effects support the hypothesis that a TPO agonist could effectively ameliorate radiation-induced neutropenia and thrombocytopenia, and stimulate megakaryopoiesis, and protect mice from radiation-induced lethality both pre- and post-exposure to TBI. This evidence concerns the gene TPO and Thrombocytopenia.